跳至主要内容
临床试验/NL-OMON43560
NL-OMON43560已完成不适用

The role of catecholaminergic neurotransmission in attention and cognition - Catecholamines, attention and cognition

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • * No use of any psychopharmacological treatment at in the past or at time of inclusion.
  • * No presence of a physical/medical condition that may interfere with the study
  • * No contradiction for MRI
  • * Age between 18 and 30
  • * right handedness

排除标准

  • * Diagnosis of a psychiatric disorder (DSM-V)
  • * Diagnosis of a neurological disorder
  • * Very high (>30) or low (>18) BMI
  • * Current recreational drug use/dependence (CIDI)
  • * Current alcohol dependence (CIDI)
  • * High blood pressure (>150 systolic, >100 diastolic)
  • * Non-responders to the mild stressor in session 1

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验